PMID- 8858410 OWN - NLM STAT- MEDLINE DCOM- 19970113 LR - 20151119 IS - 0172-4622 (Print) IS - 0172-4622 (Linking) VI - 17 IP - 5 DP - 1996 Jul TI - The influence of starch structure on glycogen resynthesis and subsequent cycling performance. PG - 373-8 AB - The present study was designed to evaluate the influence of starch structure on muscle glycogen resynthesis and cycling performance. Eight male cyclists (22 +/- 1 yr) completed an exercise protocol (DP) to decrease vastus lateralis glycogen concentration. This exercise consisted of 60 min cycling at 75% VO2max, followed by six 1-min sprints at approximately 125% VO2max with 1 min rest intervals. In the 12 hr after the exercise each subject consumed approximately 3000 kcal (65:20:15% carbohydrate, fat and protein). All of the carbohydrate (CHO) consumed was derived from one of four solutions; 1) glucose, 2) maltodextrin (glucose polymer), 3) waxy starch (100% amylopectin), or 4) resistant starch (100% amylose). Muscle biopsies were taken from the vastus lateralis muscle after DP and 24 hr later to determine glycogen concentrations. A 30 min cycling time trial (TT) was performed following the 24 hr post-DP muscle biopsy to examine the influence of the feeding regimen on total work output. The post-DP glycogen concentrations were similar among the four trials, ranging from 220.3 +/- 29.2 to 264 +/- 48.3 mmol.kg-1 dry weight (d.w.) muscle. Twenty-four hours after DP, muscle glycogen concentration had increased less (p < 0.05) in the resistant starch trial (+90.8 +/- 12.8 mmol.kg-1 d.w.) than in the glucose (+197.7 +/- 31.6 mmol.kg-1 d.w.), maltodextrin (+136.7 +/- 24.5 mmol.kg-1 d.w.) and waxy starch (+171.8 +/- 37.1 mmol.kg-1 d.w.) trials. There were no differences in total work output during the TT, or blood lactate concentration immediately following the TT in any of the CHO trials. In summary, glycogen resynthesis was attenuated following ingestion of starch with a high amylose content, relative to amylopectin or glucose; however, short duration time trial performance was unaffected. FAU - Jozsi, A C AU - Jozsi AC AD - Human Performance Laboratory, Ball State University, Muncie, Indiana 47306, USA. FAU - Trappe, T A AU - Trappe TA FAU - Starling, R D AU - Starling RD FAU - Goodpaster, B AU - Goodpaster B FAU - Trappe, S W AU - Trappe SW FAU - Fink, W J AU - Fink WJ FAU - Costill, D L AU - Costill DL LA - eng PT - Clinical Trial PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Germany TA - Int J Sports Med JT - International journal of sports medicine JID - 8008349 RN - 0 (Polysaccharides) RN - 33X04XA5AT (Lactic Acid) RN - 7CVR7L4A2D (maltodextrin) RN - 9005-79-2 (Glycogen) RN - 9005-82-7 (Amylose) RN - 9037-22-3 (Amylopectin) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Amylopectin/metabolism MH - Amylose/metabolism MH - Analysis of Variance MH - Bicycling/*physiology MH - Exercise/*physiology MH - Exercise Test MH - Glucose/metabolism MH - Glycogen/analysis/*biosynthesis MH - Humans MH - Lactic Acid/blood MH - Male MH - Muscle, Skeletal/chemistry MH - Polysaccharides/metabolism MH - Time Factors EDAT- 1996/07/01 00:00 MHDA- 1996/07/01 00:01 CRDT- 1996/07/01 00:00 PHST- 1996/07/01 00:00 [pubmed] PHST- 1996/07/01 00:01 [medline] PHST- 1996/07/01 00:00 [entrez] AID - 10.1055/s-2007-972863 [doi] PST - ppublish SO - Int J Sports Med. 1996 Jul;17(5):373-8. doi: 10.1055/s-2007-972863.